XML 65 R53.htm IDEA: XBRL DOCUMENT v2.4.1.9
Business Combinations and Asset Purchases (Narrative) (Details) (USD $)
12 Months Ended 1 Months Ended
Dec. 28, 2014
Dec. 29, 2013
Dec. 30, 2012
Nov. 30, 2012
Dec. 28, 2014
Jan. 01, 2012
Dec. 05, 2014
Oct. 21, 2014
Business Acquisition [Line Items]                
Fair Value, Measurement with Unobservable Inputs Reconciliations, Recurring Basis, Liability Value $ 91,000us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue $ 4,926,000us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue $ 3,017,000us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue   $ 91,000us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue $ 20,298,000us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue    
Business Combination, Contingent Consideration Arrangements, Description Contingent consideration is measured at fair value at the acquisition date, based on the probability that revenue thresholds or product development milestones will be achieved during the earnout period. The earnout periods for each of these acquisitions does not exceed three years from the acquisition date, and the remaining weighted average earnout period at December 28, 2014 was one year.              
Business Acquisition, Transaction Costs 3,100,000us-gaap_BusinessCombinationAcquisitionRelatedCosts 100,000us-gaap_BusinessCombinationAcquisitionRelatedCosts 1,200,000us-gaap_BusinessCombinationAcquisitionRelatedCosts          
Number of Years in Measurement Period from Acquisition Date to Change Underlying Assumptions 1 year              
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High 31,400,000us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh       31,400,000us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh      
Perten Instruments Group AB [Member]                
Business Acquisition [Line Items]                
Business Acquisition, Goodwill, Expected Tax Deductible Amount             0us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
/ us-gaap_BusinessAcquisitionAxis
= pki_PertenInstrumentsGroupABMember
 
Fiscal Year 2014 Acquisitions (excluding Perten) [Member]                
Business Acquisition [Line Items]                
Business Acquisition, Cost of Acquired Entity, Cash Paid 17,898,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= pki_FiscalYear2014AcquisitionsexcludingPertenMember
             
Working capital and other adjustments (151,000)pki_BusinessAcquisitionCostOfAcquiredEntityWorkingCapitalAdjustments
/ us-gaap_BusinessAcquisitionAxis
= pki_FiscalYear2014AcquisitionsexcludingPertenMember
             
Business Acquisition, Goodwill, Expected Tax Deductible Amount               0us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
/ us-gaap_BusinessAcquisitionAxis
= pki_FiscalYear2014AcquisitionsexcludingPertenMember
Business Acquisition, Cost of Acquired Entity, Cash Paid Including Working Capital And Other Adjustments 18,000,000pki_BusinessAcquisitionCostOfAcquiredEntityCashPaidIncludingWorkingCapitalAndOtherAdjustments
/ us-gaap_BusinessAcquisitionAxis
= pki_FiscalYear2014AcquisitionsexcludingPertenMember
             
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt               4,287,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
/ us-gaap_BusinessAcquisitionAxis
= pki_FiscalYear2014AcquisitionsexcludingPertenMember
Fiscal Year 2013 Acquisitions [Member]                
Business Acquisition [Line Items]                
Business Acquisition, Cost of Acquired Entity, Cash Paid 400,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= pki_FiscalYear2013AcquisitionsMember
11,400,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= pki_FiscalYear2013AcquisitionsMember
           
Contingent consideration   1,100,000pki_BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
/ us-gaap_BusinessAcquisitionAxis
= pki_FiscalYear2013AcquisitionsMember
           
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High   2,200,000us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
/ us-gaap_BusinessAcquisitionAxis
= pki_FiscalYear2013AcquisitionsMember
           
Human Health [Member] | Haoyuan Biotech Co. [Member]                
Business Acquisition [Line Items]                
Business Acquisition, Cost of Acquired Entity, Cash Paid       38,000,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= pki_HaoyuanBiotechCoMember
/ us-gaap_StatementBusinessSegmentsAxis
= pki_HumanHealthMember
       
Working capital and other adjustments       2,729,000pki_BusinessAcquisitionCostOfAcquiredEntityWorkingCapitalAdjustments
/ us-gaap_BusinessAcquisitionAxis
= pki_HaoyuanBiotechCoMember
/ us-gaap_StatementBusinessSegmentsAxis
= pki_HumanHealthMember
       
Contingent consideration       1,900,000pki_BusinessAcquisitionCostOfAcquiredEntityLiabilitiesIncurredContingentConsiderationAtFairValue
/ us-gaap_BusinessAcquisitionAxis
= pki_HaoyuanBiotechCoMember
/ us-gaap_StatementBusinessSegmentsAxis
= pki_HumanHealthMember
       
Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High       30,000,000us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
/ us-gaap_BusinessAcquisitionAxis
= pki_HaoyuanBiotechCoMember
/ us-gaap_StatementBusinessSegmentsAxis
= pki_HumanHealthMember
       
Human Health [Member] | Core Technology [Member] | Haoyuan Biotech Co. [Member]                
Business Acquisition [Line Items]                
Weighted average amortization period (in years)       8 years        
Human Health [Member] | Trade Names [Member] | Haoyuan Biotech Co. [Member]                
Business Acquisition [Line Items]                
Weighted average amortization period (in years)       8 years        
Environmental Health [Member] | Perten Instruments Group AB [Member]                
Business Acquisition [Line Items]                
Business Acquisition, Cost of Acquired Entity, Cash Paid         269,937,000us-gaap_PaymentsToAcquireBusinessesGross
/ us-gaap_BusinessAcquisitionAxis
= pki_PertenInstrumentsGroupABMember
/ us-gaap_StatementBusinessSegmentsAxis
= pki_EnvironmentalHealthMember
     
Working capital and other adjustments         0pki_BusinessAcquisitionCostOfAcquiredEntityWorkingCapitalAdjustments
/ us-gaap_BusinessAcquisitionAxis
= pki_PertenInstrumentsGroupABMember
/ us-gaap_StatementBusinessSegmentsAxis
= pki_EnvironmentalHealthMember
     
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt             $ 7,600,000us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesLongTermDebt
/ us-gaap_BusinessAcquisitionAxis
= pki_PertenInstrumentsGroupABMember
/ us-gaap_StatementBusinessSegmentsAxis
= pki_EnvironmentalHealthMember
 
Environmental Health [Member] | Minimum [Member] | Perten Instruments Group AB [Member]                
Business Acquisition [Line Items]                
Weighted average amortization period (in years)         5 years      
Environmental Health [Member] | Maximum [Member] | Perten Instruments Group AB [Member]                
Business Acquisition [Line Items]                
Weighted average amortization period (in years)         10 years